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CURRENT RESEARCH 
Electromagnetic (EM) fields have been used therapeutically for accelerated 
healing and pain control, but they have also been associated with adverse 
health effects. To understand these biological effects, we have been 
studying the interaction of low frequency EM fields with cells at both the 
cellular and molecular levels. Our studies with cells have shown that 60Hz 
EM fields induce stress genes and stress response proteins in cells. The 
stress response is a protective mechanism induced by many potentially 
harmful environmental stimuli and characterized by the synthesis of specific 
proteins that assist the renaturation and transport of other proteins. Our 
studies suggest that EM fields initiate the stress response by interacting 
with electrons moving within DNA. We have identified a 900 base pair 
segment associated with the response to EM fields, that when removed 
eliminates the response, and when transfected into a reporter construct. 
causes the construct to become EM field responsive. We have also 
investigated the mechanism of EM field interactions at the molecular level 
through effects on three reactions, electron transfer in cytochrome oxidase, 
ATP hydrolysis by the Na,K-ATPase, and the Belousov-Zhabotinski (BZ) 
reaction (the catalyzed oxidation of malonic acid). The BZ reaction is 
studied with ordinary reagents, so there is no problem of impurities as with 
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biological preparatiohs. All three reactions show: 
• EM accelerates the reaction rate, i.e., electron transfer rate 
• EM competes with the chemical force, so its effect varies inversely 
with the reaction rate thresholds for interaction are low, comparable 
to levels found by epidemiology effects vary with frequency, and 
there are different optima for the reactions studied: ATPase (60Hz), 
cytochrome oxidase (800Hz), BZ (250Hz) 
These properties are consistent with the idea that EM fields affect many 
biological systems by interacting with electrons moving during redox 
reactions and also within DNA. 
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Martin Blank Testimony on EMF 
Q. What is your name and busif)ess address? 
A. My name is Martin Blank, Ph.D. My business address is Department of 
Physiology and Cellular Biophysics, College of Physicians and Surgeons, 
Columbia University, New York, NY 10032. 
Q. Where do you work? 
A. I am Associate Professor of Physiology and Cellular Biophysics, College of 
Physicians and Surgeons, Columbia University, New York, NY 10032. 
Q. What is your educational background? 
A. I have a Ph.D. from Columbia University (1957) in physical chemistry, and a 
Ph.D. from Cambridge University (1959), England, in colloid science, an 
interdisciplinary (biology, physics and chemistry) department. 
Q. Where have you worked in addition to Columbia University and Cambridge 
University? 
A. My experience includes research, teaching and management of research 
programs in various academic, industrial and US government settings, 
including: • Polymer Department, Weizmann Institute (Israel); • Bioengineering 
Department, University of California-Berkeley; • Pharmacology Department, 
Hebrew University (Israel); • Biochemistry Department, Monash University 
(Australia), • Frumkin Institute of Electrochemistry (Moscow, USSR), • 
Biophysics Department, University of Warsaw (Poland), • Chemical Physics 
Department, Tata Institute for Fundamental Research (India), • Chemistry 
Department, University of the Negev (Israel) and • Biology Department, 
University of Victoria (Canada). My industrial research experience includes: • 
California Research Corporation, Richmond, CA, • Esso Research and 
Engineering Corporation, Linden, NJ, and • Unilever Research Laboratories in 
Port Sunlight and Welwyn, England and Vlaardingen, the Netherlands. I have 
also worked for the US Office of Naval Research (ONR) as a Liaison Scientist in 
London (UK) and as a Program Officer in Arlington (US), where I developed and 
managed a research program in biomembrane electrochemistry. I have also 
consulted for other research agencies, including American Institute of Biological 
Sciences (AIBS) and Electric Power Research Institute (EPRI), as well as 
private corporations. This wide range of professional experience has given me a 
broad perspective on scientific research, and has made me receptive to a 
variety of approaches in bioelectromagnetic research. 
Q. What are your responsibilities at Columbia University? 
A. My primary responsibility is to conduct research, which for the last twenty 
years has focused on electromagnetic (EM) fields and their effects on cell 
biochemistry and cell membrane function. I have recently specialized in the 
study of stress proteins and charge transport enzymes (specific biological 
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catalysts). I have also taught Medical Physiology to first year medical, dental 
and graduate students, including a year as Course Director in charge of 250 
students. Throughout my career, I have served as officer of scientific societies, 
editor of scientific journals, reviewer of scientific papers for publication and 
proposals for funding, as well as expert advisor, as in the evaluation of the 
performance of research laboratories for government agencies. 
Q. How have your professional experiences contributed to a better 
understanding of biological effects of EM fields? 
A. My experience has impressed upon me the value of interdisciplinary 
approaches to complex problems. Of particular relevance have been my roles: • 
at ONR-London, where I wrote a report on the importance of interdisciplinary 
research in scientific progress • as Chairman of the Organic and Biological 
Division of the Electrochemical Society, President of the Bioelectrochemical 
Society, and President of the Bioelectromagnetics Society, in which I organized 
interdisciplinary symposia. • as organizer of large interdisciplinary meetings, 
including the 4th International Symposium on Bioelectrochemistry (1976), the 
first Gordon Research Conference on Bioelectrochemistry (1980), and four 
interdisciplinary courses at Erice (Italy). The Gordon Conference catalyzed the 
organization of the First (1992) and Second (1997) World Congresses on 
Electricity and Magnetism in Biology and Medicine, meetings that brought 
together experts from the different areas needed for understanding all aspects 
of the EM field problem. • as editor of the Journal of the Electrochemical Society 
(DiVisional Editor for Biology) and Bioelectrochemistry and Bioenergetics (North 
American Editor), where I encouraged contributions using interdisciplinary 
approaches. • as author of over 200 papers and reviews, as well as twelve 
edited books on electrical properties of biological systems. Among these books 
are the Q. Proceedings of the First World Congress on "Electricity and 
Magnetism in Biology and Medicine", Q. "Biomembrane Electrochemistry", 
based on the ONR program, Q. "Nerve-Muscle Function", based on the 4th 
Erice (Italy) course, Q. "ElectromagnetiC Fields: Biological Interactions and 
Mechanisms" for the authoritative American Chemical Society series, Advances 
in Chemistry. The book focuses on cellular mechanisms in biological 
interactions of EM fields. 
Q. What is your professional assessment regarding the safety of human 
exposure to low frequency EM fields? 
A. Concern about health risks from low frequency EM fields in the environment 
arose from epidemiological studies linking certain cancers with exposure to 
power frequency (50-60Hz) EM fields, and the focus has remained on the 
epidemiology. In 1979, Wertheimer and Leeper showed a doubling in the 
incidence of leukemia in children associated with EM fields, but epidemiology 
studies since then have not been conclusive. A consensus appeared to be 
developing after the NIEHS instituted a comprehensive review of a wide range 
of evidence that included three symposia of experts, a critical review of the 
peer-reviewed literature and a detailed written report. The NIEHS-EMF review 
panel announced in June 1998 that magnetic fields should be considered a 
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"possible human carcinogen" based primarily on epidemiological studies, but 
including some laboratory research as well. Since then two meta analyses 
(Greenland et ai, Epidem 2000; Ahlbom et ai, Brit J Cancer 2000), of 15 and 9 
major studies respectively, have shown a statistically significant doubling of the 
risk of childhood leukemia when exposures exceed 3-4mG. Epidemiology can 
demonstrate association, not causation, but the results of the meta analyses 
appear convincing. A doubling of risk of leukemia has persisted in many studies 
near the "significant" level (as in the National Cancer Institute study), and the 
lack of statistical significance has been due to the low number of cases at high 
exposure in individual studies. By pooling the cases of many studies in a meta 
analysis, it has been possible to demonstrate statistical significance. The 
epidemiological evidence is strong enough to serve as a basis for practical 
decisions, but this is only one approach to the problem. Controlled laboratory 
research is needed to provide a rationale, to make the association plausible, 
and a detailed mechanism to help develop mitigation strategies. This is the area 
in which laboratory research in several disciplines has provided important 
insights that have strengthened the mechanistic basis for the epidemiology 
conclusions. 
Q. Can you explain how your research has contributed to understanding 
interactions of cells with low frequency EM fields, and how this elucidates the 
epidemiology results? 
A. Let me start by explaining some scientific terms (in bold). The DNA molecule 
in a cell nucleus is a long, tightly coiled, double helix. The two strands of the 
helix are connected by four interacting chemicals called bases given the 
symbols C, G, A, and T. In human DNA there are about 3 billion bases that 
interact as pairs, C with G and A with T, one base from each strand. The 
sequence of the bases along the DNA is in a code needed to make the proteins 
essential for life, a code that is being deciphered in the "Human Genome" 
project. Each protein is encoded in a separate segment called a gene, and 
specific genes are activated by specific chemicals in regions called promoters. 
After activation, proteins are synthesized in two steps, transcription (making a 
copy of the DNA code of the gene in the form of messenger RNA (mRNA), and 
translation (using the mRNA to synthesize the protein). The integrity of the DNA 
is essential for life, since the information for making proteins cannot be changed 
without damage to the cell. An accumulation of changes (mutations) in the DNA 
is associated with the development of cancers, diseases that are believed to 
arise from a multi-step process: initiation (damage to DNA in at least two 
places), promotion (effect on cellular processes that causes loss of control) and 
progression (tumor growth). EM fields have been mentioned as possible 
promoters, and Trosko et al. (Environ Health Perspec, 2000) showed that 40mG 
fields can mimic the effects of chemical promoters. Cancer mechanisms are not 
well understood, and different mechanisms may be operating in each specific 
tissue. The synthesis of proteins in a cell is regulated by feedback control that 
supplies particular proteins as needed. When there is a potentially harmful 
change in a cell's environment (a stress), stress proteins are synthesized. The 
stress response, first identified in reaction to elevated temperatures, is used by 
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all species in response to harmful environmental stimuli (e.g., low oxygen, toxic 
metal ions). My studies with my colleagues concerning changes in both 
transcription and translation induced by EM fields, have shown that cells react 
to 60Hz EM fields as a stress and make stress proteins. Now in response to the 
question, stimulation of the stress response by EM fields: • indicates that cells 
react to EM fields as a harmful stimulus • shows that EM fields activate DNA 
and protein synthesis • occurs at field strengths slightly above normal 
background levels. 
Q. How do the stress proteins activated by EM fields differ from those thermally 
activated? 
A. The stress proteins stimulated by EM fields are identical to those stimulated 
by an increase in temperature, and both use the same protein synthesis 
pathway. However, in response to EM fields, cells also use a pathway that 
requires remarkably low energy input. In Sciara salivary gland cells, the 
threshold energies of the EM field and thermal stimuli needed to evoke a stress 
response differ by 14 orders of magnitude, as shown in the Table below. 
ENERGY to STIMULATE STRESS RESPONSE Form of Energy Stimulus 
Energy Density Ooules/m3) Magnetic O.BoT 2.6 x 10-7 Thermal 5.50C 2.3 x 
10+7 
Q. Are specific regions of DNA associated with the response to EM fields? 
A. Since reviewing EM field stimulation of the stress response (Goodman and 
Blank, Cell Stress and Chaperones 199B), we have identified specific DNA 
sequences that are EM field-responsive. There are three -CTCT- sequences in 
the promoter of the major stress protein (hsp70) and eight in the promoter of 
another EM field-responsive protein. Inactivating these sequences by removal 
or mutation, eliminates the response to EM fields. Inserting sequences into an 
artificial construct containing a gene, makes the gene EM field-responsive. 
Linkage of EM field responses with specific regions of DNA is important for 
gene therapy, since this provides a non-invasive, precise technique for gene 
activation. Columbia University has filed a patent application for this process 
based on our research. 
Q. Do the specific DNA sequences suggest how EM fields activate DNA? 
A. Stimulation of transcription may occur when magnetic fields accelerate 
electrons moving within DNA (Blank and Goodman, Bioelectromagnetics 1997). 
Recent studies show that DNA conducts electrons along the bases within the 
double helix, and we have shown that EM fields accelerate electron transfer 
reaction rates. The velocity of charge movement calculated from experiments 
with the enzyme, Na,K-ATPase, 1000 mIs, is similar to ultrafast electron 
transfer in DNA of 400 m/s. At these velocities, the forces at low field strengths 
affect enzyme reactions, and so they may be large enough to interact with 
moving electrons in DNA and generate repulsive forces that cause chain 
separation. From estimates of the balance of forces (repulsion-attraction) at the 
DNA bases, sites rich in C and T, as in the identified -CTCT- sequences, 
appear to be more likely to come apart when repulsive forces are generated by 
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EM fields. These calculations (Blank and Goodman, J Cell Biochem, in press) 
suggest a plausible mechanism for initiation of transcription by EM fields, and 
provide a rationale for EM field specific sequences. 
Q. Are there studies showing interaction of EM fields with charge movements in 
other biological molecules? 
A. EM fields accelerate moving charges in any conductor. To determine how 
EM fields affect charges in biological molecules, we have studied two relatively 
simple systems, the enzymes Na,K-ATPase and cytochrome oxidase. A 
summary of changes in their activity in EM fields is given below: • magnetic 
fields accelerate both enzyme reactions • for both enzymes, the acceleration 
increases with EM field strength. • the EM field competes with the chemical 
forces driving the reaction, i.e., when the enzyme rate is very fast, there is no 
increase due to the field. • for both reactions, the threshold EM field is below 
5mG. • the rate constant for cytochrome oxidase has a broad maximum about 
800Hz, and for Na,K-ATPase the frequency maximum is about 60Hz. Both 
frequencies are close to the optimal enzyme reaction rates and suggest that the 
EM field coordinates with the enzyme reaction. • EM fields accelerate electron 
transfer reactions in the absence of cells, enzymes or membranes. We have 
studied electron transfer in malonic acid solutions, and found results similar to 
the two enzyme reactions (including competition between EM field and intrinsic 
chemical driving forces). 
Q. Is there other evidence for interaction of EM fields with DNA? 
A. Many studies (laboratories of Phillips, WoloshaCk) have shown that EM fields 
stimulate transcription (DNA into mRNA). There are also studies that show 
increases in cell proliferation (an acceleration of cell division) as a result of 
exposure to EM fields (laboratories of Kwee, Berg, Parola). Also, the many 
clinical studies showing effects on the rate of healing of bone fractures and soft 
tissues (pioneering research of Bassett, Becker) indicate effects of EM fields on 
cellular processes at the level of DNA. 
Q. How do the molecular mechanisms stimulated by EM fields relate to cancer 
mechanisms? 
A. As mentioned above, cancer mechanisms are not well understood, but over-
expression of stress proteins has been linked to a number of human tumors. 
The high concentrations of stress genes in a number of human tumors has 
made them markers for the disease, e.g., hsp90 is a marker for breast cancer. 
Hsp70 stress proteins are known to interact with proteins, such as c-myc and 
mutant p53, that cause cellular transformation and are associated with many 
cancers. The hsp 70 promoter is regulated by the tumor suppressor p53, a 
transcription factor implicated in over 500/0 of human cancers. Another link of 
EM field exposures to cancer is modification of the tumor suppressing action of 
melatonin secreted by the pineal gland in the brain. Studies replicated in four 
labs show that a low EM field strength of 12mG blocks the growth-inhibiting 
action of melatonin on human estrogen receptor-positive, breast cancer cells, 
as well as the near-complete blockage of the anticancer (chemotherapeutic) 
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drug Tamoxifen. A field strength of 2mG has no effect, indicating that the 
threshold lies between 2mG and 12mG. 
Q. What have we learned from threshold measurements for biological effects of 
EM fields? 
A. Low thresholds have been measured in several independent systems, and 
the values have been published in peer review journals. The Table below shows 
that the measured thresholds for changes in enzyme activity and in biosynthesis 
of stress proteins are within an order of magnitude, and in the range of cut-off 
thresholds in epidemiological studies. The last entry is for EM field blockage of 
the inhibition of breast cancer cell growth by melatonin is an upper limit. All the 
thresholds are below field strengths measured near transmission lines, so the 
biological systems would be stimulated. Biological EM Field Thresholds 
Enzymes: Na,K-ATPase 2-3mG Cytochrome C Oxidase 5-6mG Ornithine 
decarboxylase 20mG DNA: Stress proteins (HL60 Cells) 8mG Stress proteins 
(Sciara Cells) 8mG Cells: Block inhibition by melatonin (Breast cancer cells) 
12mG Epidemiology threshold 3-4mG 
Q. How do you address the criticism that is raised when some biologists cannot 
repeat published experiments showing positive effects of EM fields on 
transcription? 
A. The biological research has been distorted by the emphasis on cancer 
research. Instead of studying well defined, reliable biological models, such as E. 
coli, yeast and drosophila, there has been a focus on transformed cells, such as 
leukemia cells (e.g., HL60), that have the disadvantage of being highly variable. 
It is now clear that conflicting results about a central problem in EM field effects, 
the stimulation of transcription, arose because HL60 cells were used, and the 
cell populations used in different laboratories have very different properties. 
HL60 cells from the A TCC (American Tissue Culture Center) grow at half the 
rate of those supplied by the CUCC (Columbia University Cancer Center), and 
are also much less reactive to chemical agents and to EM fields. In a recent 
paper (Jin et ai, 1997), the conflicting results were shown to depend on the very 
different growth rates and reactivities of the HL60 cells. The positive reports that 
EM fields stimulate transcription were replicated, and the conflicting reports 
explained. 
Q. The American Physical Society has written a report saying that biological 
effects at low field levels (below the noise level) are theoretically not possible. 
How do you reply? 
A. It is tempting to simply dismiss the statements of a group whose expertise is 
so far afield from medical and biological issues, but the issue can be answered 
with two questions. 
Q. Are the physicists aware of research in biology that contradicts their 
conclusion? Q. Are the models they use relevant to cellular processes? 
The answers to both questions are NO. From my replies to earlier questions it 
should be clear that many laboratories have shown that weak EM fields can 
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have significant effects on cells (e.g., reaction rates and protein synthesis as in 
the stress response). The task of the theoretician is to develop realistic models 
for the observations. The commonly used models for cells, where a membrane 
is the only cell structure, are unrealistic and not even relevant for stimulation of 
transcription in the DNA of the cell nucleus. Calculations based on unrealistic 
models can only lead to irrelevant conclusions. A famous example is Lord 
Kelvin, the most respected physicist of his time, who used an unrealistic model 
and came to the wrong conclusion about the age of the earth. Geologists 
correctly proposed that the earth was billions of years old, but Kelvin calculated 
that if the earth were that old, heat at the earth's core would have diffused away, 
and the earth would have cooled into a solid mass. Since the earth had a 
molten core, the age estimated by geologists was wrong. Kelvin's model did not 
take into account heating from radioactive decay, a phenomenon that was not 
discovered until many years later. Theoreticians must use models that relate to 
transcription, if they hope to arrive at reasonable conclusions about effects of 
EM fields on transcription. Theoreticians who claim that biological effects of EM 
fields are impossible at levels weaker than thermal noise (the energy due to 
random molecular motion) must acknowledge that the extreme sensitivity of 
sharks to electric fields is well below the thermal noise limit. Sharks have an 
elaborate inter-connected system of sensors that is able to detect fields as low 
as nanovolts/cm. Biological systems often have unusual properties (e.g., retinal 
cells can react to a single quantum of light). Physicists must develop models 
that are appropriate for the biological measurements they are meant to explain. 
Q. How would you summarize the current strength of the evidence on the 
linkage between EM fields and cancer? 
A. As more is learned about EM field interactions with cells, the plausibility of a 
link between low frequency EM fields and childhood leukemia can be put 
forward with growing confidence. • epidemiological results point to a doubling of 
the risk of childhood leukemia associated with exposure to EM fields in excess 
of 3-4mG. • stimulation of the cellular stress response (a cellular protective 
mechanism) by EM fields indicates that cells react to EM fields as a harmful 
stimulus • laboratory studies show that weak EM fields can affect cellular 
processes, thresholds for cellular effects are in the range of environmental EM 
fields. • a cellular mechanism has been identified, the cellular stress response, 
which is an appropriate response to a potentially harmful environmental 
influence. • a molecular mechanism, interaction of EM fields with moving 
charges, is physically reasonable, and has been shown to apply in several 
molecular systems. • stimulation of protein synthesis by EM fields is probably 
due to direct interaction with DNA, since a specific DNA sequence has been 
associated with the response. • clinical studies with therapeutic EM devices 
show accelerated healing, indicating effects on biological growth processes. 
Q. In light of what is known about the epidemiology and the laboratory studies 
on EM fields, what do you think is a reasonable practical policy to follow? 
A. The recommendations of the NIEHS Report to the Congress (May 1999) are 
the most reasonable ones to follow while we continue to study the problem. 
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Kenneth Olden, the Director of NIEHS, wrote that " ... ELF-EMF exposure cannot 
be recognized at this time as entirely safe ... passive regulatory action is 
warranted such as a continued emphasis on educating both the public and the 
regulated community [i.e., the power companies] on means aimed at reducing 
exposures." On page 38 of the Report, the recommendation is more explicit. 
"The NIEHS suggests that the power industry continue its current practice of 
siting power lines to reduce exposures and continue to explore ways to reduce 
the creation of magnetic fields around transmission and distribution lines without 
creating new hazards." 
http://www.sunfishlake.org/NEWS/martin_blank_testimony_on_emf.htm 
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